Erfan Taherifard

Postdoctoral Associate

DownloadHi-Res Photo

About

Titles

Postdoctoral Associate

Departments & Organizations

All Institutions
Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT)
Internal Medicine

Education & Training

MPH: Shiraz University of Medical Sciences (2022)

MD: Shiraz University of Medical Sciences (2022)

Research

Research at a Glance

Yale Co-Authors

Frequent collaborators of Erfan Taherifard's published research.

Ashkan Abdollahi, MD
View Full Profile
View Common Publication

Publications

2025

Solid Tumor Incidence and Patterns in Individuals With Down Syndrome: A Systematic Review and Meta-Analysis.
Taherifard E, Taherifard E, Bouffet E, Satgé D, Abdelbaki MS. Solid Tumor Incidence and Patterns in Individuals With Down Syndrome: A Systematic Review and Meta-Analysis. Pediatr Blood Cancer 2025, 72: e31775. PMID: 40358422, DOI: 10.1002/pbc.31775.
Peer-Reviewed Original Research
Characteristics of patients with disseminated Bacillus Calmette-Guérin infection: a retrospective study at Namazi Hospital, Southern Iran, from 1991 to 2022.
Sanaei Dashti A, Soflaee Shahrbabak S, Malekzadeh Y, Davarpanah A, Taherifard E, Ahmadkhani A, Pouladfar G, Hamzavi SS, Kadivar MR, Geramizadeh B, Anbardar MH, Shoja K, Taherifard E. Characteristics of patients with disseminated Bacillus Calmette-Guérin infection: a retrospective study at Namazi Hospital, Southern Iran, from 1991 to 2022. J Trop Pediatr 2025, 71 PMID: 40499196, DOI: 10.1093/tropej/fmaf023.
Peer-Reviewed Original Research
Association of individual and community-level socioeconomic status and education with medication use: a multilevel analysis in the PERSIAN cohort.
Akbari M, Poustchi H, Taherifard E, Mehrian SRA, Rahimian Z, Mesgarpour B, Pourfarzi F, Gharekhani A, Nejatizadeh A, Moradpour F, Piraie E, Fakhraei B, Joukar F, Saki N, Safarpour AR, Moradinazar M, Rezaianzadeh A, Tafaghodi M, Esmaeili-Nadimi A, Moslem A, Alijanvand MH, Moosazadeh M, Mehrparvar AH, Ansari-Moghaddam A, Taherifard E, Ghahramani S, Pakroo M, Mohammadi Z, Malekzadeh R, Vardanjani HM. Association of individual and community-level socioeconomic status and education with medication use: a multilevel analysis in the PERSIAN cohort. BMC Public Health 2025, 25: 1842. PMID: 40389946, DOI: 10.1186/s12889-025-23062-y.
Peer-Reviewed Original Research
The Effect of Zataria multiflora on Clinical, Pulmonary Function, and Oxidant Factors in Patients With Pulmonary Diseases: A Meta-Analysis of Clinical Trials.
Aali A, Taherifard E, Farshidianfar M, Hadianfard F, Alamdari F, Keshavarzian O, Nimrouzi M, Heydari ST, Akbari M. The Effect of Zataria multiflora on Clinical, Pulmonary Function, and Oxidant Factors in Patients With Pulmonary Diseases: A Meta-Analysis of Clinical Trials. Health Sci Rep 2025, 8: e70772. PMID: 40330764, DOI: 10.1002/hsr2.70772.
Peer-Reviewed Original Research
Factors Associated With Electrocardiographic Abnormalities in Patients With Sickle Cell Disease: A Systematic Review and Meta-Analysis.
Zare P, Ahmadkhani A, Taherifard E, Apelian S, Behjoo H, Taherifard E. Factors Associated With Electrocardiographic Abnormalities in Patients With Sickle Cell Disease: A Systematic Review and Meta-Analysis. Pediatr Blood Cancer 2025, 72: e31585. PMID: 39950513, DOI: 10.1002/pbc.31585.
Peer-Reviewed Original Research
ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non-Hodgkin's Lymphoma.
Dehghani M, Vojdani R, Khalafi-Nezhad A, Ravanbod MR, Ramzi M, Dehdashti S, Taherifard E, Namdari N. ESHAP versus IEV Chemotherapy for Relapsed or Refractory Hodgkin's and Non-Hodgkin's Lymphoma. Int J Hematol Oncol Stem Cell Res 2025, 19: 151-157. PMID: 40852693, DOI: 10.18502/ijhoscr.v19i2.18552.
Peer-Reviewed Original Research

2024

Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review.
Taherifard E, Tran K, Saeed A, Yasin JA, Saeed A. Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review. Diagnostics (Basel) 2024, 14 PMID: 39335733, DOI: 10.3390/diagnostics14182054.
Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran.
Amini A, Taherifard E, Akbari M, Taherifard E, Dehdari Ebrahimi N, Rajabi MR, Zamani F, Rekabpour SJ, Jafaraghaie R, Hassanzadeh J, Molavi Vardanjani H. The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran. Expert Rev Hematol 2024, 17: 643-650. PMID: 39061121, DOI: 10.1080/17474086.2024.2385482.
Peer-Reviewed Original Research
Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer.
Taherifard E, Saeed A. Neoadjuvant PD-1/PD-L1 inhibitors plus chemotherapy in resectable gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2024, 9: 59. PMID: 39503035, DOI: 10.21037/tgh-24-44.
Commentaries, Editorials and Letters
Epidemiological and clinical characteristics of long COVID-19 among Iranians: A community-based study in southern Iran.
Askarian M, Taherifard E, Jazzabi F, Shayan Z, Assadian O, Groot G, Hatam N, Askarian A, Faghihi SM, Taherifard E. Epidemiological and clinical characteristics of long COVID-19 among Iranians: A community-based study in southern Iran. BMC Public Health 2024, 24: 2007. PMID: 39061051, DOI: 10.1186/s12889-024-19543-1.
Peer-Reviewed Original Research